Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125834111 | 12583411 | 1 | I | 20160714 | 20160722 | 20160722 | EXP | CA-PFIZER INC-2016353416 | PFIZER | 40.00 | YR | M | Y | 0.00000 | 20160722 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125834111 | 12583411 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | U | 0 | ||||||||||
| 125834111 | 12583411 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 11719 | |||||||||
| 125834111 | 12583411 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125834111 | 12583411 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | U | 0 | |||||||||
| 125834111 | 12583411 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125834111 | 12583411 | 6 | SS | SECUKINUMAB | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QWK | U | 0 | 300 | MG | INJECTION | /wk | |||||
| 125834111 | 12583411 | 7 | SS | SORIATANE | ACITRETIN | 1 | Unknown | UNK | U | 0 | CAPSULE | ||||||||
| 125834111 | 12583411 | 8 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125834111 | 12583411 | 4 | Psoriasis |
| 125834111 | 12583411 | 6 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125834111 | 12583411 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125834111 | 12583411 | Drug ineffective | |
| 125834111 | 12583411 | Headache | |
| 125834111 | 12583411 | Injection site haemorrhage | |
| 125834111 | 12583411 | Injection site swelling | |
| 125834111 | 12583411 | Insomnia | |
| 125834111 | 12583411 | Muscular weakness | |
| 125834111 | 12583411 | Myalgia | |
| 125834111 | 12583411 | Nausea | |
| 125834111 | 12583411 | Pain in extremity | |
| 125834111 | 12583411 | Psoriasis | |
| 125834111 | 12583411 | Vein rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |